PATENT CLAIM ANALYSIS

Application Number: 16165602
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "044000"]

Abstract:
Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.

Claim (Index 4):
A pharmaceutical composition comprising the DNA vaccine of  claim 1 , and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13031396', '13968854', '14614137', '11848607', '15238016']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8608768618561911
- 35 USC 102 Novelty (BERT): 0.7233456268050772
- Combined Prediction Score: 0.8471237383510797
- Mean Citation Score: 766.5322600000003
- Max Citation Score: 783.5026
- Similarity Product: 779.8939204425693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test